People · Operator
Named in public records as an officer, director or promoter · active 2012–2015 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Akcea Therapeutics, Inc. | — | Pharmaceuticals | Growth/Late | $543.2M | $19.7B | 2015 |
| Isis Pharmaceuticals Inc | — | Pharmaceuticals | Series D+ | $201.3M | $7.1B | 2012 |
STANLEY T CROOKE at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside STANLEY T CROOKE on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| B. Lynne Parshall | 2 | 3 |
| JOSEPH R KLEIN III | 1 | 1 |
| BRETT P MONIA | 1 | 1 |
| SPENCER R BERTHELSEN | 1 | 1 |
| JOHN C REED | 1 | 1 |
| FREDERICK T MUTO | 1 | 1 |
| RICHARD S GEARY | 1 | 1 |
| JOSEPH H WENDER | 1 | 1 |
| C FRANK BENNETT | 1 | 1 |
| PATRICK L. O'NEIL | 1 | 1 |
| ELIZABETH L. HOUGEN | 1 | 1 |
| JEFFREY L. GOLDBERG | 1 | 1 |
| PAULA LYNNE SOTEROPOULOS | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.